Home/Viatris/Scott A. Smith
SA

Scott A. Smith

Chief Executive Officer

Viatris

Viatris Pipeline

DrugIndicationPhase
Semglee (insulin glargine biosimilar)DiabetesApproved
Mvasi (bevacizumab biosimilar)OncologyApproved
Ogivri (trastuzumab biosimilar)Breast CancerApproved
EpiPenAnaphylaxisApproved
LipitorCardiovascular DiseaseApproved
LyricaNeuropathic PainApproved
NorvascHypertensionApproved
ViagraErectile DysfunctionApproved